Reduced density of cholinergic interneurons in the ventral striatum in Schizophrenia: An in situ hybridization study

Biological Psychiatry

Volumn 58, Issue 5, 2005, Pages 408-416

  Holt, Daphne J ^a   Bachus, Susan E ^b   Hyde, Thomas M ^b   Wittie, Michael ^b   Herman, Mary M ^b   Vangel, Mark ^a   Saper, Clifford B ^c   Kleinman, Joel E ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Basal ganglia; Cholinergic; In situ hybridization; Postmortem; Schizophrenia; Striatum

Indexed keywords

BETA ACTIN; CHOLINE ACETYLTRANSFERASE; MESSENGER RNA; PREPROSOMATOSTATIN; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAUDATE NUCLEUS; CELL DENSITY; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTERNEURON; MALE; OLIGONUCLEOTIDE PROBE; PRIORITY JOURNAL; PUTAMEN; SCHIZOPHRENIA;

ADULT; AGED; BASAL GANGLIA; CELL COUNT; CHOLINE O-ACETYLTRANSFERASE; FEMALE; HUMANS; IN SITU HYBRIDIZATION; INTERNEURONS; MALE; MIDDLE AGED; POSTMORTEM CHANGES; SCHIZOPHRENIA;

EID: 24044528136     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.04.007     Document Type: Article

References (63)

1. E.D. Bird, E.G. Spokes, J. Barnes, A.V. MacKay, L.L. Iversen, M. Shepherd Increased brain dopamine and reduced glutamic acid decarboxylase and choline acetyl transferase activity in schizophrenia and related psychoses Lancet 2 1977 1157 1158
2. E.D. Bird, E.G. Spokes, L.L. Iversen Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia Brain 102 1979 347 360
3. H. Braak, E. Braak Neuronal types in the striatum of man Cell Tissue Res 277 1982 319 342
4. C.R. Breese, M.J. Lee, C.E. Adams, B. Sullivan, J. Logel, K.M. Gillen Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia Neuropsychopharmacology 23 2000 351 364
5. D.R. Burt, I. Creese, S.H. Snyder Antischizophrenic drugs Chronic treatment elevates dopamine receptor binding in brain Science 196 1977 326 328
6. M.H. Chakos, J.A. Lieberman, R.M. Bilder, M. Borenstein, G. Lerner, B. Bogerts Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs Am J Psychiatry 151 1994 1430 1436
7. A. Chang, P.P. Li, J.J. Warsh cAMP-Dependent protein kinase (PKA) subunit mRNA levels in postmortem brain from patients with bipolar affective disorder (BD) Brain Res Mol Brain Res 116 2003 27 37
8. G. Chen, T.G. Gharib, C.C. Huang, J.M. Taylor, D.E. Misek, S.L. Kardia Discordant protein and mRNA expression in lung adenocarcinomas Mol Cell Proteomics 1 2002 304 313
9. J. Chen, B.K. Lipska, N. Halim, Q.D. Ma, M. Matsumoto, S. Melhem Functional analysis of genetic variation in catechol-O-methyltransferase (COMT) Effects on mRNA, protein, and enzyme activity in postmortem human brain Am J Hum Genet 75 2004 807 821
10. M.F. Chesselet, L. Weiss, C. Wuenschell, A.J. Tobin, H.U. Affolter Comparative distribution of mRNAs for glutamic acid decarboxylase, tyrosine hydroxylase, and tachykinins in the basal ganglia an in situ hybridization study in the rodent brain J Comp Neurol 262 1987 125 140
11. J.A. Court, M.A. Piggott, S. Lloyd, N. Cookson, C.G. Ballard, I.G. McKeith Nicotine binding in human striatum Elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication Neuroscience 98 2000 79 87
12. B. Dean, J.M. Crook, K. Opeskin, C. Hill, N. Keks, D.L. Copolov The density of muscarinic M1 receptors is decreased in the caudate- putamen of subjects with schizophrenia Mol Psychiatry 1 1996 54 58
13. B. Dean, J.M. Crook, G. Pavey, K. Opeskin, D.L. Copolov Muscarinic 1 and 2 receptor mRNA in the human caudate-putamen No change in m1 mRNA in schizophrenia Mol Psychiatry 5 2000 203 207
14. A.Y. Deutch Identification of the neural systems subserving the actions of clozapine Clues from immediate-early gene expression J Clin Psychiatry 55 suppl B 1994 37 42
15. G. Di Chiara, M. Morelli, S. Consolo Modulatory functions of neurotransmitters in the striatum ACh/dopamine/NMDA interactions Trends Neurosci 17 1994 228 233
16. E.F. Domino, R.R. Krause, J. Bowers Various enzymes involved with putative neurotransmitters. Regional distribution in the brain of deceased mentally normal, chronic schizophrenics or organic brain syndrome patients Arch Gen Psych 29 1973 195 201
17. N. Durany, R. Zochling, K.W. Boissl, W. Paulus, G. Ransmayr, T. Tatschner Human post-mortem striatal alpha4beta2 nicotinic acetylcholine receptor density in schizophrenia and Parkinson's syndrome Neurosci Lett 287 2000 109 112
18. E. Friedman, G. Gianutsos, J. Kuster Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding implications for understanding tardive dyskinesia J Pharmacol Exp Ther 226 1983 7 12
19. J.I. Friedman Cholinergic targets for cognitive enhancement in schizophrenia Focus on cholinesterase inhibitors and muscarinic agonists Psychopharmacology (Berl) 174 2004 45 53
20. P.A. Frohna, B.S. Neal-Beliveau, J.N. Joyce Neonatal 6-OHDA lesions upregulate adult expression of tyrosine hydroxylase mRNA Neuroreport 4 1993 1095 1098
21. A.A. Grace Gating of information flow within the limbic system and the pathophysiology of schizophrenia Brain Res Brain Res Rev 31 2000 330 341
22. A.M. Graybiel, C.W. Ragsdale Biochemical anatomy of the striatum P.C. Emson Chemical Neuroanatomy 1983 Raven Press New York 427 504
23. J.W. Grimm, M.A. Chapman, D.S. Zahm, R.E. See Decreased choline acetyltransferase immunoreactivity in discrete striatal subregions following chronic haloperidol in rats Synapse 39 2001 51 57
24. H. Gross, E. Kaltenback Neuropathological findings in persistent hyperkinesia after neuroleptic long-term therapy A. Cerletti F.J. Bove The Present Status of Psychotropic Drugs Pharmacological and Clinical Aspects 1969 Excerpta Medica Amsterdam 474 476
25. P. Gunning, P. Ponte, H. Okayama, J. Engel, H. Blau, L. Kedes Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed Mol Cell Biol 3 1983 787 795
26. S.N. Haber, N.R. McFarland The concept of the ventral striatum in nonhuman primates Ann N Y Acad Sci 877 1999 33 48
27. P.J. Harrison, P.R. Heath, S.L. Eastwood, P.W. Burnet, B. McDonald, R.C. Pearson The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies Selective mRNA vulnerability and comparison with their encoded proteins Neurosci Lett 200 1995 151 154
28. S. Heckers, D. Mash, C. Guela, M.-M. Mesulam Basal forebrain and striatal cholinergic neurons in schizophrenia Soc Neurosci Abstr 19 1993 838
29. D.J. Holt, M.M. Herman, T.M. Hyde, J.E. Kleinman, C.M. Sinton, D.C. German Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia Neuroscience 94 1999 21 31
30. D.J. Holt, L.B. Hersh, C.B. Saper Cholinergic innervation in the human striatum A three-compartment model Neuroscience 74 1996 67 87
31. T.M. Itil, S. Keskiner, J.M. Holden The use of LSD and ditran in the treatment of therapy resistant schizophrenics (symptom provocation approach) Dis Nerv Syst 30 1969 93 103
32. K. Jellinger Neuropathologic findings after neuroleptic long-term therapy L. Roizin H. Shiraki N. Grcevic Neurotoxicology 1977 Raven Press New York 25 42
33. K. Jellinger Neuromorphological background of pathochemical studies in major psychoses H. Beckmann P. Riederer Pathochemical Markers in Major Psychoses 1985 Springer-Verlag Heidelberg 1 23
34. E.C. Johnstone, T.J. Crow, I.N. Ferrier, C.D. Frith, D.G. Owens, R.C. Bourne Adverse effects of anticholinergic medication on positive schizophrenic symptoms Psychol Med 13 1983 513 527
35. M.S. Keshevan, W.W. Bagwell, G.L. Hass, J.A. Sweeney, N.R. Schooler, J.W. Pettegrew Changes in caudate volume with neuroleptic treatment Lancet 344 1994 1434
36. Z.S. Khachaturian Diagnosis of Alzheimer's disease Arch Neurol 42 1985 1097 1105
37. C. Konradi, S. Heckers Antipsychotic drugs and neuroplasticity Insights into the treatment and neurobiology of schizophrenia Biol Psychiatry 50 2001 729 742
38. M. Laruelle, A. Abi-Dargham, R. Gil, L. Kegeles, R. Innis Increased dopamine transmission in schizophrenia Relationship to illness phases Biol Psychiatry 46 1999 56 72
39. M. Laruelle, L.S. Kegeles, A. Abi-Dargham Glutamate, dopamine, and schizophrenia From pathophysiology to treatment Ann N Y Acad Sci 1003 2003 138 158
40. J. Lehmann, S.Z. Langer The striatal cholinergic interneuron Synaptic target of dopaminergic terminals? Neuroscience 10 1983 1105 1120
41. M.E. Lewis, T.G. Sherman, S.J. Watson In situ hybridization histochemistry with synthetic oligonucleotides Strategies and methods Peptides 6 suppl 2 1985 75 87
42. J.B. Lohr, M.P. Caligiuri, M.S. Manley, J.A. Browning Neuroleptic-induced striatal damage in rats a study of antioxidant treatment using accelerometric and immunocytochemical methods Psychopharmacology (Berl) 148 2000 171 179
43. S.P. Mahadik, H. Laev, A. Korenovsky, S.E. Karpiak Haloperidol alters rat CNS cholinergic system Enzymatic and morphological analyses Biol Psychiatry 24 1988 199 217
44. S.P. Mahadik, S. Mukherjee Monosialoganglioside cotreatment prevents haloperidol treatment - associated loss of cholinergic enzymes in rat brain Biol Psychiatry 38 1995 246 254
45. P.L. McGeer, E.G. McGeer Possible changes in striatal and limbic cholinergic systems in schizophrenia Arch Gen Psych 34 1977 1319 1323
46. R. Miller, G. Chouinard Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia Biol Psychiatry 34 1993 713 738
47. N.R. Mirza, D. Peters, R.G. Sparks Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists CNS Drug Rev 9 2003 159 186
48. S. Mithani, S. Atmadja, K.G. Baimbridge, H.C. Fibiger Neuroleptic-induced oral dyskinesias Effects of progabide and lack of correlation with regional changes in glutamic acid decarboxylase and choline acetyltransferase activities Psychopharmacology (Berl) 93 1987 94 100
49. M. Mousavi, E. Hellstrom-Lindahl, Z.Z. Guan, K.R. Shan, R. Ravid, A. Nordberg Protein and mRNA levels of nicotinic receptors in brain of tobacco using controls and patients with Alzheimer's disease Neuroscience 122 2003 515 520
50. G. Nagasaka Zur Pathologie der extrapyramidalen Zentren bei Schizophrenie Arb Neurol Inst Univ Wien 27 1925 363 396
51. F. Pedata, S. Sorbi, G. Pepeu Choline high-affinity uptake and metabolism and choline acetyltransferase activity in the striatum of rats chronically treated with neuroleptics J Neurochem 35 1980 606 611
52. T.J. Raedler, M.B. Knable, D.W. Jones, R.A. Urbina, J.G. Gorey, K.S. Lee In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia Am J Psychiatry 160 2003 118 127
53. G.S. Robertson, H. Matsumura, H.C. Fibiger Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity J Pharmacol Exp Ther 271 1994 1058 1066
54. N.M.J. Rupniak, R.S. Briggs, M.M. Petersen, S. Mann, C. Reavill, P. Jenner Differential alterations in striatal acetylcholine function in rats during 12 months' continuous administration of haloperidol, sulpiride, or clozapine Clin Neuropharmacol 9 1986 282 292
55. P. Seeman, M. Chau-Wong, J. Tedesco, K. Wong Brain receptors for antipsychotic drugs and dopamine Direct binding assays Proc Natl Acad Sci U S A 72 1975 4376 4380
56. P. Seeman, T. Lee, M. Chau-Wong, K. Wong Antipsychotic drug doses and neuroleptic/dopamine receptors Nature 261 1976 717 719
57. L.P. Shen, W.J. Rutter Sequence of the human somatostatin I gene. Science 224:168-171. Singh MM, Kay SR, Opler LA (1987): Anticholinergic-neuroleptic antagonism in terms of positive and negative symptoms of schizophrenia: Implications for psychobiological subtyping Psychol Med 17 1984 39 48
58. A.D. Smith, J.P. Bolam The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones Trends Neurosci 13 1990 259 265
59. R. Tandon, N.A. Mann, W.H. Eisner, N. Coppard Effect of anticholinergic medication on positive and negative symptoms in medication-free schizophrenic patients Psychiatry Res 31 1990 235 241
60. A.V. Terry Jr, W.D. Hill, V. Parikh, J.L. Waller, D.R. Evans, S.P. Mahadik Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats Neuropsychopharmocology 28 2003 300 309
61. Q. Tian, S.B. Stepaniants, M. Mao, L. Weng, M.C. Feetham, M.J. Doyle Integrated genomic and proteomic analyses of gene expression in Mammalian cells Mol Cell Proteomics 3 2004 960 969
62. J.L. Toussaint, V. Geoffroy, M. Schmitt, A. Werner, J.M. Garnier, P. Simoni Human choline acetyltransferase (CHAT) Partial gene sequence and potential control regions Genomics 12 1992 412 416
63. M. Wittie, S.E. Bachus, D.J. Holt, T.M. Hyde, J.E. Kleinman, M.E. Egan Striatal ChAT mRNA levels following chronic haloperidol Soc Neurosci Abstr 27 2001 232